Jim co-founded Provell Pharmaceuticals and currently serves as Chief Executive Officer. He brings over 30 years of Pharmaceutical Sales, Marketing, and Drug Development experience having worked with several large pharmaceutical companies.
Kurt Kalm along with Jim Small co-founded Provell Pharmaceuticals in 2005 and serves as CFO and Managing Partner. Kurt brings a wealth of experience in Investment Banking, Mergers & Acquisitions and Pharmaceutical Drug Development.
Steve joined Provell Pharmaceuticals in 2016 and currently serves as Chief Operating Officer. He brings over 17 years of pharmaceutical sales/marketing and training experience and has previously worked within Fortune 100 Pharmaceutical Companies. His current role includes oversight of daily operations, pharmacovigilance, quality, sales, marketing, and supply chain management.
Vice President of Sales
Kevin Smith recently joined Provell Pharmaceuticals as VP of Sales in July of 2019. He has spent 34 years in the US pharmaceutical market and the past 28 years in the generic segment. Previously, Kevin held the role of Sr. VP of Sales and Marketing with Lannett Company, Inc for the past 16.5 years. He was instrumental in growing the sales of “levothyroxine sodium tablets” which was Lannett’s # 1 product. Kevin is excited to grow the Euthyrox business for Provell.
Director of Quality Assurance
Shannon joined Provell Pharmaceuticals in 2018 and currently serves as Director - Quality Assurance. She brings over 5 years of quality and auditing experience and has previously worked within a major third-party logistics (3PL) company for 10 years. Her role currently includes oversight of Provell's Quality System.
Director of Quality Assurance
Heather joined Provell Pharmaceuticals in September of 2019 and currently serves as Director - Quality Assurance. Heather brings over 12 years of Quality Assurance experience, with nearly 9 years within the pharmaceutical industry having worked with a prominent contract manufacturing organization and safety testing facility. Her current role will utilize her knowledge and expertise acquired during those years as they relate to drug product manufacturing, release, and quality systems.
Kim Gibson, MSM
Director of Operations
Kim joined Provell Pharmaceuticals in the Summer of 2019 and brings over 20 years of Customer Service, Logistics, and Supply Chain Management within a major third-party logistics (3PL) company. Her current role will include the day-to-day operations related to production, customer and sales support, and supply chain management.
Hua Wang, CPA, MSA
Hua joined Provell Pharmaceuticals in August 2020 and brings over 20 years of in-depth experience in various accounting and finance roles spanning from small to medium sized businesses across diverse markets. Her responsibilities include overseeing all aspects of accounting functions for Provell, including AR, AP, Capex, PR, GL, cash flow projections, compiling of financial statements, budgets, and forecasts.